chr10-100235720-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_018294.6(CWF19L1):āc.1419A>Cā(p.Thr473=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00135 in 1,612,474 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00091 ( 0 hom., cov: 32)
Exomes š: 0.0014 ( 2 hom. )
Consequence
CWF19L1
NM_018294.6 synonymous
NM_018294.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.899
Genes affected
CWF19L1 (HGNC:25613): (CWF19 like cell cycle control factor 1) This gene encodes a member of the CWF19 protein family. Mutations in this gene have been associated with autosomal recessive spinocerebellar ataxia-17 and mild cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 10-100235720-T-G is Benign according to our data. Variant chr10-100235720-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 715239.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.899 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000906 (138/152348) while in subpopulation NFE AF= 0.00168 (114/68042). AF 95% confidence interval is 0.00143. There are 0 homozygotes in gnomad4. There are 68 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CWF19L1 | NM_018294.6 | c.1419A>C | p.Thr473= | synonymous_variant | 13/14 | ENST00000354105.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CWF19L1 | ENST00000354105.10 | c.1419A>C | p.Thr473= | synonymous_variant | 13/14 | 1 | NM_018294.6 | P1 | |
CWF19L1 | ENST00000478047.1 | n.1574A>C | non_coding_transcript_exon_variant | 4/5 | 2 | ||||
CWF19L1 | ENST00000468709.5 | c.*969A>C | 3_prime_UTR_variant, NMD_transcript_variant | 12/13 | 2 | ||||
CWF19L1 | ENST00000482452.5 | c.*806A>C | 3_prime_UTR_variant, NMD_transcript_variant | 11/13 | 5 |
Frequencies
GnomAD3 genomes AF: 0.000907 AC: 138AN: 152230Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
138
AN:
152230
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000852 AC: 213AN: 250080Hom.: 0 AF XY: 0.000872 AC XY: 118AN XY: 135340
GnomAD3 exomes
AF:
AC:
213
AN:
250080
Hom.:
AF XY:
AC XY:
118
AN XY:
135340
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00140 AC: 2042AN: 1460126Hom.: 2 Cov.: 29 AF XY: 0.00138 AC XY: 1003AN XY: 726466
GnomAD4 exome
AF:
AC:
2042
AN:
1460126
Hom.:
Cov.:
29
AF XY:
AC XY:
1003
AN XY:
726466
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000906 AC: 138AN: 152348Hom.: 0 Cov.: 32 AF XY: 0.000913 AC XY: 68AN XY: 74500
GnomAD4 genome
AF:
AC:
138
AN:
152348
Hom.:
Cov.:
32
AF XY:
AC XY:
68
AN XY:
74500
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | CWF19L1: BP4, BP7 - |
CWF19L1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 19, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at